Or Not?

We have noticed a disregard for the appropriate use of the word "first" in scientific articles in the past year. While there is certainly some prestige with being the first author(s) to describe a new scientific finding or unusual clinical entity, invoking this distinction should be done only after a thorough and meticulous literature search warrants it and only when such a claim of priority has some relevance of importance.For example, one paper described the first reportedly successful implant

Written byJames Bradley Summers
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

We have noticed a disregard for the appropriate use of the word "first" in scientific articles in the past year. While there is certainly some prestige with being the first author(s) to describe a new scientific finding or unusual clinical entity, invoking this distinction should be done only after a thorough and meticulous literature search warrants it and only when such a claim of priority has some relevance of importance.

For example, one paper described the first reportedly successful implantation of a biventricular pacemaker in Thailand.1 Another article elaborated one of the first laparoscopy-assisted aneurysm repair[s] in Japan.2 A third concerned the first case of food-dependent, exercise-inducted anaphylaxis in Thailand. Another described the first case of metastatic tumor in the right orbit at a university in Krakow.4

While it may seem reasonable to utilize "first" in the title, such as in unusual infections that might be of some epidemiological significance, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies